LGL GROUP INC quarterly report, Q3 FY2015

LGL Group, Inc. — Q3 2015 Form 10-Q Summary

Business context and reporting period

The filing covers the three and nine months ended September 30, 2015. LGL is a holding company whose principal operating business, MtronPTI, designs and manufactures highly engineered, high-reliability frequency and spectrum control products. Its strategy is to shift from lower-margin commodity products toward more complex products, particularly for aerospace and defense markets.

Financial results and liquidity

MetricQ3 2015Q3 2014Nine months 2015Nine months 2014
Revenue$4.796 million$5.581 million$15.671 million$17.562 million
Gross margin33.1%31.0%33.0%26.7%
Operating loss$154,000$409,000$648,000$2.501 million
Net loss$195,000$492,000$574,000$2.570 million
Loss per share, basic and diluted$0.07$0.19$0.22$0.99
Cash from operating activitiesNot separately presented by quarter$1.025 million$(1.094) million

At September 30, cash and cash equivalents were $5.941 million, current assets were $12.106 million, and current liabilities were $2.318 million. Working capital was $9.788 million and the current ratio was 5.22 to 1. Total assets were $16.117 million and stockholders’ equity was $13.799 million. The company reported no balance outstanding on its $3.0 million revolving credit facility and no related restricted cash. The facility runs through September 30, 2016, subject to possible extension, and borrowings require matching cash collateral.

Nine-month investing cash use was $276,000, including $370,000 of capital expenditures. Cash increased by $749,000 during the period. The filing reports $25,000 of net interest expense for the nine months and no cash interest paid in 2015. No cash dividends are expected for the foreseeable future.

Material changes and management commentary

  • Revenue declined 14.1% in Q3 and 10.8% for the first nine months. Management attributed pressure to offshore price competition, particularly in Internet Communications Technology products, and the decision to move away from low-margin commodity business.
  • Gross margin improved by 2.1 percentage points in Q3 and 6.3 points year to date, attributed to favorable product mix and margin initiatives. The 2014 year-to-date comparison also included $366,000 of warranty expense related to two isolated product defects.
  • Operating results improved alongside lower engineering, selling and administrative costs following a 2014 restructuring. Year-to-date 2014 also included $444,000 of restructuring expense.
  • Backlog was $8.783 million at quarter-end, compared with $8.857 million at June 30, 2015 and $8.693 million a year earlier. Management said it expects to fill the entire backlog within 12 months, but cannot assure the timing or amount fulfilled in any given year.
  • Year-to-date other income included approximately $159,000 of net insurance proceeds for damaged equipment and inventory. Operating cash flow benefited from reduced losses and working-capital changes.

Outlook, risks and unusual items

  • Management believes existing cash and operating cash generation will cover working capital and capital expenditure needs for the next 12 months, while noting it may seek capital for growth or strategic objectives. No numerical revenue or earnings guidance was provided.
  • The company maintains a full valuation allowance against U.S. deferred tax assets because realization is uncertain. It reported a $13,000 income tax provision for the nine-month period.
  • Cash equivalents included $4.089 million invested in Treasury money market funds managed by an entity related through a common director; management directed the transactions.
  • A $43,000 impairment of a note receivable was recorded in the first nine months. The company also issued 37,296 fully vested restricted shares to its CEO, with $160,000 of compensation expense, and granted executives 32,000 options.
  • The company reported no material legal proceedings, no new risk factors in this filing, and no off-balance-sheet arrangements. Management stated disclosure controls were effective and reported no material changes in internal control over financial reporting.

Important facts for investors to verify

  • Whether the shift toward higher-margin aerospace and defense products can stabilize or grow revenue despite continued price pressure.
  • Backlog conversion, including the timing and cancellation or deferral risk, and whether backlog supports the stated 12-month expectation.
  • Whether margin gains and restructuring-related cost savings are sustainable, especially in light of prior product warranty defects.
  • The sustainability of operating cash flow and the company’s 12-month liquidity assessment; note the related-party management of a substantial portion of cash equivalents.
  • The unused revolving facility’s extension terms and cash-collateral requirements, and the potential effects of the full tax valuation allowance.